Hao X, Zhu X, Tian H, Lai G, Zhang W, Zhou H, Liu S
Consider the typical changes across all dimensions
Pharmacovigilance and signal detection FAERS semaglutide disproportionality (broad): A FAERS-based disproportionality analysis of semaglutide reports through mid-2023 identified multiple unexpected adverse event signals and explicitly notes that some signals were not mentioned in the drug insert, including polycystic ovaries. The analysis highlights typical spontaneous-reporting limitations (missing age, outcome data)
Water for Injections Ph.Eur Summary of Product Characteristics
Monotherapy with metformin versus sulfonylureas and risk of cancer in type 2 diabetic patients: a systematic review and meta-analysis
This step-by-step method helps your body adjust and reduces early side effects